市場調查報告書

全球睡眠協助市場:按睡眠障礙提供的行業分析和到2030年的增長預測

Sleeping Aids Market Research Report: By Offering, Sleep Disorder - Global Industry Analysis and Growth Forecast to 2030

出版商 Prescient & Strategic Intelligence Private Limited 商品編碼 968423
出版日期 內容資訊 英文 216 Pages
商品交期: 2-3個工作天內
價格
全球睡眠協助市場:按睡眠障礙提供的行業分析和到2030年的增長預測 Sleeping Aids Market Research Report: By Offering, Sleep Disorder - Global Industry Analysis and Growth Forecast to 2030
出版日期: 2020年07月01日內容資訊: 英文 216 Pages
簡介

2019年全球睡眠援助市場為787億美元。到2020年至2030年,該市場預計將以7.1%的複合年增長率增長,到2030年將達到1625億美元。

推動市場增長的主要因素是醫療機構的數量增加,便攜式睡眠設備的使用增加以及傳感器和可穿戴顯示器的採用增加。

本報告調查了全球睡眠援助市場,包括市場規模和預測,趨勢,機會,增長和限制因素,COVID-19影響,供應/睡眠障礙/區域市場分析以及競爭。它提供了諸如主要公司的狀況和概況之類的信息。

目錄

第1章調查背景

  • 調查目的
  • 市場定義
  • 調查範圍
    • 報價
    • 睡眠障礙
    • 按地區
    • 分析期間
    • 市場數據報告單位
      • 交易量
  • 主要利益相關者

第2章調查方法

第3章執行摘要

第4章簡介

  • 市場細分的定義
    • 報價
      • 床墊/枕頭
      • 睡眠測試服務
      • 藥物
      • 睡眠吸引器
      • 其他
    • 睡眠障礙
      • 失眠
      • 失眠的願望
      • RLS
      • 嗜睡症
      • 夢夢病
      • 其他
  • 市場動態
    • 趨勢
      • 將消費者的偏好轉向草藥非處方藥
      • 在家中對睡眠測試的需求增加
      • 增加使用CPAP治療設備
    • 生長因子
      • 失眠和OSA患病率增加
      • 便攜式睡眠抽吸設備的使用增加
      • 政府對初創公司的支持增加
      • 醫療機構網絡的發展
      • 廣泛採用可穿戴式顯示器和傳感器
      • 由於壓力大的現代生活方式,對安眠藥的需求迅速增加
      • 老年人口增加
      • 分析增長因素對市場預測的影響
    • 抑製器
      • 漫長的睡眠護理服務等待時間
      • 缺乏熟練的醫療專業人員
      • 睡眠障礙藥物專利到期
      • 與安眠藥有關的副作用
      • 分析限制因素對市場預測的影響
    • 市場機會
      • 可支配收入增加
      • 新興經濟體患者儲備的增加
      • 各種組織採取的提高意識的舉措
  • 波特的五力分析
  • COVID-19的影響

第5章全球市場規模和預測

  • 報價
    • 按類型:睡眠藥品市場
    • 按類型:睡眠吸引設備市場
  • 睡眠障礙
  • 按國家

第6章北美市場規模和預測

第7章歐洲市場規模和預測

第8章亞太市場規模和預測

第9章拉丁美洲市場規模和預測

第10章中東/非洲的市場規模和預測

第11章競爭情況

  • 主要公司的產品基準
  • 大公司的戰略發展
    • 產品發佈和批准
    • 併購
    • 聯盟,合作,合同
    • 其他

第12章公司簡介

  • Sanofi
  • Merck & Co. Inc.
  • Koninklijke Philips N.V.
  • Pfizer Inc.
  • SleepMed Inc.
  • Cadwell Industries Inc.
  • Natus Medical Incorporated
  • Drive DeVilbiss Healthcare
  • Takeda Pharmaceutical Company Limited
  • Compumedics Limited
  • Tempur Sealy International Inc.
  • GlaxoSmithKline plc
  • Serta Simmons Bedding LLC
  • ResMed Inc.
  • Fisher & Paykel Healthcare Limited
  • Lowenstein Medical GmbH & Co. KG
  • BMC Medical Co. Ltd.
  • SomnoMed Limited
  • BRAEBON Medical Corporation

第13章附錄

  • 縮寫
  • 來源和參考
  • 相關報告
目錄

Title:
Sleeping Aids Market Research Report: By Offering (Mattresses and Pillows, Sleep Laboratory Services, Medication, Sleep Apnea Devices), Sleep Disorder (Insomnia, Sleep Apnea, Restless Legs Syndrome, Narcolepsy, Sleep Walking) - Global Industry Analysis and Growth Forecast to 2030.

The global sleeping aids market generated a revenue of $78.7 billion in 2019 and is predicted to progress at a CAGR of 7.1% from 2020 to 2030. As per the market research firm, P&S Intelligence, the market would attain a value of $162.5 billion by 2030. The major factors driving the progress of the market are the increasing number of healthcare facilities, growing usage of portable sleep apnea devices, and the rising adoption of sensors and wearable monitors.

Besides the aforementioned factors, the increasing prevalence of obstructive sleep apnea (OSA) and insomnia and the soaring geriatric population around the world are also propelling the expansion of the sleeping aids market. As per the findings of the American Sleep Apnea Association, over 50 million Americans are diagnosed with 80 different sleep disorders every year. Moreover, the organization found that 20-30 million people in the U.S. suffer from various intermittent sleep problems every year.

According to the organization, insomnia is the most prevalent sleep disorder, with nearly 30% of the adults living in the U.S. reporting short-term issues and around 10% reporting chronic insomnia. As the medical treatments prescribed for OSA and insomnia involve sleeping aids, the rising incidence of these disorders is fueling the growth of the market. Besides this, the various lifestyle changes in people such as the high consumption of caffeine, tobacco, and alcohol is also propelling the market advancement.

Furthermore, the increasing working hours, high workload and work pressure, and hectic work environment massively push up the stress levels and affect the quality of sleep. This subsequently boosts the sales of over-the-counter (OTC) sleeping pills, which help improve the quality of sleep, throughout the globe. When offering is taken into consideration, the sleeping aids market is classified into mattresses and pillows, sleep laboratory services, sleep apnea devices, and medication.

Table of Contents

Chapter 1. Research Background

  • 1.1 Research Objectives
  • 1.2 Market Definition
  • 1.3 Research Scope
    • 1.3.1 Market Segmentation by Offering
    • 1.3.2 Market Segmentation by Sleep Disorder
    • 1.3.3 Market Segmentation by Geography
    • 1.3.4 Analysis Period
    • 1.3.5 Market Data Reporting Unit
      • 1.3.5.1 Value
  • 1.4 Key Stakeholders

Chapter 2. Research Methodology

  • 2.1 Secondary Research
  • 2.2 Primary Research
    • 2.2.1 Split of Primary Research
    • 2.2.2 Breakdown of Primary Research by Industry Participant
    • 2.2.3 Breakdown of Primary Research by Company Type
    • 2.2.4 Breakdown of Primary Research by Company Revenue and Corporate Designation
  • 2.3 Baseline Methodology
  • 2.4 Market Size Estimation
  • 2.5 Data Triangulation
  • 2.6 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

  • 4.1 Definition of Market Segments
    • 4.1.1 By Offering
      • 4.1.1.1 Mattresses and pillows
      • 4.1.1.2 Sleep laboratory services
      • 4.1.1.3 Medication
        • 4.1.1.3.1 Prescription drugs
        • 4.1.1.3.2 OTC drugs
        • 4.1.1.3.3 Herbal remedies
      • 4.1.1.4 Sleep apnea devices
        • 4.1.1.4.1 PAP devices
        • 4.1.1.4.2 Facial interface
        • 4.1.1.4.3 Oral appliances
        • 4.1.1.4.4 ASVs
        • 4.1.1.4.5 Others
      • 4.1.1.5 Others
    • 4.1.2 By Sleep Disorder
      • 4.1.2.1 Insomnia
      • 4.1.2.2 Sleep apnea
      • 4.1.2.3 RLS
      • 4.1.2.4 Narcolepsy
      • 4.1.2.5 Sleep walking
      • 4.1.2.6 Others
  • 4.2 Market Dynamics
    • 4.2.1 Trends
      • 4.2.1.1 Shifting consumer preference toward herbal OTC drugs
      • 4.2.1.2 Increasing demand for home sleep tests
      • 4.2.1.3 Increased usage of CPAP therapy devices
    • 4.2.2 Drivers
      • 4.2.2.1 Growing prevalence of insomnia and OSA
      • 4.2.2.2 Rising use of portable sleep apnea devices
      • 4.2.2.3 Increasing government support for startup companies
      • 4.2.2.4 Growing network of healthcare facilities
      • 4.2.2.5 Growing adoption of wearable monitors and sensors
      • 4.2.2.6 Surge in demand for sleeping pills, attributed to stressful modern lifestyle
      • 4.2.2.7 Increasing geriatric population
      • 4.2.2.8 Impact analysis of drivers on market forecast
    • 4.2.3 Restraints
      • 4.2.3.1 Long waiting time for sleep care services
      • 4.2.3.2 Shortage of skilled medical professionals
      • 4.2.3.3 Patent expiration of sleep disorder medications
      • 4.2.3.4 Side-effects associated with sleep medications
      • 4.2.3.5 Impact analysis of restraints on market forecast
    • 4.2.4 Opportunities
      • 4.2.4.1 Rising disposable income
      • 4.2.4.2 Increasing patient pool in emerging economies
      • 4.2.4.3 Initiatives by various organizations for increasing awareness
  • 4.3 Porter's Five Forces Analysis
  • 4.4 Impact of COVID-19

Chapter 5. Global Market Size and Forecast

  • 5.1 By Offering
    • 5.1.1 Sleeping Aid Medication Market, by Type
    • 5.1.2 Sleep Apnea Devices Market, by Type
  • 5.2 By Sleep Disorder
  • 5.3 By Region

Chapter 6. North America Market Size and Forecast

  • 6.1 By Offering
    • 6.1.1 Sleeping Aid Medication Market, by Type
    • 6.1.2 Sleep Apnea Devices Market, by Type
  • 6.2 By Sleep Disorder
  • 6.3 By Country
    • 6.3.1 U.S. Sleeping Aids Market
      • 6.3.1.1 By offering
        • 6.3.1.1.1 Sleeping aid medication market, by type
        • 6.3.1.1.2 Sleep apnea devices market, by type
      • 6.3.1.2 By sleep disorder
    • 6.3.2 Canada Sleeping Aids Market
      • 6.3.2.1 By offering
        • 6.3.2.1.1 Sleeping aid medication market, by type
        • 6.3.2.1.2 Sleep apnea devices market, by type
      • 6.3.2.2 By sleep disorder

Chapter 7. Europe Market Size and Forecast

  • 7.1 By Offering
    • 7.1.1 Sleeping Aid Medication Market, by Type
    • 7.1.2 Sleep Apnea Devices Market, by Type
  • 7.2 By Sleep Disorder
  • 7.3 By Country
    • 7.3.1 Germany Sleeping Aids Market
      • 7.3.1.1 By offering
        • 7.3.1.1.1 Sleeping aid medication market, by type
        • 7.3.1.1.2 Sleep apnea devices market, by type
      • 7.3.1.2 By sleep disorder
    • 7.3.2 U.K. Sleeping Aids Market
      • 7.3.2.1 By offering
        • 7.3.2.1.1 Sleeping aid medication market, by type
        • 7.3.2.1.2 Sleep apnea devices market, by type
      • 7.3.2.2 By sleep disorder
    • 7.3.3 France Sleeping Aids Market
      • 7.3.3.1 By offering
        • 7.3.3.1.1 Sleeping aid medication market, by type
        • 7.3.3.1.2 Sleep apnea devices market, by type
      • 7.3.3.2 By sleep disorder
    • 7.3.4 Italy Sleeping Aids Market
      • 7.3.4.1 By offering
        • 7.3.4.1.1 Sleeping aid medication market, by type
        • 7.3.4.1.2 Sleep apnea devices market, by type
      • 7.3.4.2 By sleep disorder
    • 7.3.5 Spain Sleeping Aids Market
      • 7.3.5.1 By offering
        • 7.3.5.1.1 Sleeping aid medication market, by type
        • 7.3.5.1.2 Sleep apnea devices market, by type
      • 7.3.5.2 By sleep disorder

Chapter 8. APAC Market Size and Forecast

  • 8.1 By Offering
    • 8.1.1 Sleeping Aid Medication Market, by Type
    • 8.1.2 Sleep Apnea Devices Market, by Type
  • 8.2 By Sleep Disorder
  • 8.3 By Country
    • 8.3.1 Japan Sleeping Aids Market
      • 8.3.1.1 By offering
        • 8.3.1.1.1 Sleeping aid medication market, by type
        • 8.3.1.1.2 Sleep apnea devices market, by type
      • 8.3.1.2 By sleep disorder
    • 8.3.2 China Sleeping Aids Market
      • 8.3.2.1 By offering
        • 8.3.2.1.1 Sleeping aid medication market, by type
        • 8.3.2.1.2 Sleep apnea devices market, by type
      • 8.3.2.2 By sleep disorder
    • 8.3.3 India Sleeping Aids Market
      • 8.3.3.1 By offering
        • 8.3.3.1.1 Sleeping aid medication market, by type
        • 8.3.3.1.2 Sleep apnea devices market, by type
      • 8.3.3.2 By sleep disorder

Chapter 9. LATAM Market Size and Forecast

  • 9.1 By Offering
    • 9.1.1 Sleeping Aid Medication Market, by Type
    • 9.1.2 Sleep Apnea Devices Market, by Type
  • 9.2 By Sleep Disorder
  • 9.3 By Country

Chapter 10. MEA Market Size and Forecast

  • 10.1 By Offering
    • 10.1.1 Sleeping Aid Medication Market, by Type
    • 10.1.2 Sleep Apnea Devices Market, by Type
  • 10.2 By Sleep Disorder
  • 10.3 By Country

Chapter 11. Competitive Landscape

  • 11.1 Product Benchmarking of Key Players
  • 11.2 Strategic Developments of Key Players
    • 11.2.1 Product Launches and Approvals
    • 11.2.2 Mergers and Acquisitions
    • 11.2.3 Partnerships, Collaborations and Agreements
    • 11.2.4 Others

Chapter 12. Company Profiles

  • 12.1 Sanofi
    • 12.1.1 Business Overview
    • 12.1.2 Product and Service Offerings
    • 12.1.3 Key Financial Summary
  • 12.2 Merck & Co. Inc.
    • 12.2.1 Business Overview
    • 12.2.2 Product and Service Offerings
    • 12.2.3 Key Financial Summary
  • 12.3 Koninklijke Philips N.V.
    • 12.3.1 Business Overview
    • 12.3.2 Product and Service Offerings
    • 12.3.3 Key Financial Summary
  • 12.4 Pfizer Inc.
    • 12.4.1 Business Overview
    • 12.4.2 Product and Service Offerings
    • 12.4.3 Key Financial Summary
  • 12.5 SleepMed Inc.
    • 12.5.1 Business Overview
    • 12.5.2 Product and Service Offerings
  • 12.6 Cadwell Industries Inc.
    • 12.6.1 Business Overview
    • 12.6.2 Product and Service Offerings
  • 12.7 Natus Medical Incorporated
    • 12.7.1 Business Overview
    • 12.7.2 Product and Service Offerings
    • 12.7.3 Key Financial Summary
  • 12.8 Drive DeVilbiss Healthcare
    • 12.8.1 Business Overview
    • 12.8.2 Product and Service Offerings
  • 12.9 Takeda Pharmaceutical Company Limited
    • 12.9.1 Business Overview
    • 12.9.2 Product and Service Offerings
    • 12.9.3 Key Financial Summary
  • 12.10 Compumedics Limited
    • 12.10.1 Business Overview
    • 12.10.2 Product and Service Offerings
    • 12.10.3 Key Financial Summary
  • 12.11 Tempur Sealy International Inc.
    • 12.11.1 Business Overview
    • 12.11.2 Product and Service Offerings
    • 12.11.3 Key Financial Summary
  • 12.12 GlaxoSmithKline plc
    • 12.12.1 Business Overview
    • 12.12.2 Product and Service Offerings
    • 12.12.3 Key Financial Summary
  • 12.13 Serta Simmons Bedding LLC
    • 12.13.1 Business Overview
    • 12.13.2 Product and Service Offerings
  • 12.14 ResMed Inc.
    • 12.14.1 Business Overview
    • 12.14.2 Product and Service Offerings
    • 12.14.3 Key Financial Summary
  • 12.15 Fisher & Paykel Healthcare Limited
    • 12.15.1 Business Overview
    • 12.15.2 Product and Service Offerings
    • 12.15.3 Key Financial Summary
  • 12.16 Lowenstein Medical GmbH & Co. KG
    • 12.16.1 Business Overview
    • 12.16.2 Product and Service Offerings
  • 12.17 BMC Medical Co. Ltd.
    • 12.17.1 Business Overview
    • 12.17.2 Product and Service Offerings
  • 12.18 SomnoMed Limited
    • 12.18.1 Business Overview
    • 12.18.2 Product and Service Offerings
    • 12.18.3 Key Financial Summary
  • 12.19 BRAEBON Medical Corporation
    • 12.19.1 Business Overview
    • 12.19.2 Product and Service Offerings

Chapter 13. Appendix

  • 13.1 Abbreviations
  • 13.2 Sources and References
  • 13.3 Related Reports

LIST OF TABLES

  • TABLE 1 ANALYSIS PERIOD OF THE STUDY
  • TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 4 GLOBAL SLEEPING AIDS MARKET, BY OFFERING, $M (2014-2019)
  • TABLE 5 GLOBAL SLEEPING AIDS MARKET, BY OFFERING, $M (2020-2030)
  • TABLE 6 GLOBAL SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014-2019)
  • TABLE 7 GLOBAL SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2020-2030)
  • TABLE 8 GLOBAL SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014-2019)
  • TABLE 9 GLOBAL SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2020-2030)
  • TABLE 10 GLOBAL SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014-2019)
  • TABLE 11 GLOBAL SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2020-2030)
  • TABLE 12 GLOBAL SLEEPING AIDS MARKET, BY REGION, $M (2014-2019)
  • TABLE 13 GLOBAL SLEEPING AIDS MARKET, BY REGION, $M (2020-2030)
  • TABLE 14 NORTH AMERICA SLEEPING AIDS MARKET, BY OFFERING, $M (2014-2019)
  • TABLE 15 NORTH AMERICA SLEEPING AIDS MARKET, BY OFFERING, $M (2020-2030)
  • TABLE 16 NORTH AMERICA SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014-2019)
  • TABLE 17 NORTH AMERICA SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2020-2030)
  • TABLE 18 NORTH AMERICA SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014-2019)
  • TABLE 19 NORTH AMERICA SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2020-2030)
  • TABLE 20 NORTH AMERICA SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014-2019)
  • TABLE 21 NORTH AMERICA SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2020-2030)
  • TABLE 22 NORTH AMERICA SLEEPING AIDS MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 23 NORTH AMERICA SLEEPING AIDS MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 24 U.S. SLEEPING AIDS MARKET, BY OFFERING, $M (2014-2019)
  • TABLE 25 U.S. SLEEPING AIDS MARKET, BY OFFERING, $M (2020-2030)
  • TABLE 26 U.S. SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014-2019)
  • TABLE 27 U.S. SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2020-2030)
  • TABLE 28 U.S. SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014-2019)
  • TABLE 29 U.S. SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2020-2030)
  • TABLE 30 U.S. SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014-2019)
  • TABLE 31 U.S. SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2020-2030)
  • TABLE 32 CANADA SLEEPING AIDS MARKET, BY OFFERING, $M (2014-2019)
  • TABLE 33 CANADA SLEEPING AIDS MARKET, BY OFFERING, $M (2020-2030)
  • TABLE 34 CANADA SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014-2019)
  • TABLE 35 CANADA SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2020-2030)
  • TABLE 36 CANADA SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014-2019)
  • TABLE 37 CANADA SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2020-2030)
  • TABLE 38 CANADA SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014-2019)
  • TABLE 39 CANADA SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2020-2030)
  • TABLE 40 EUROPE SLEEPING AIDS MARKET, BY OFFERING, $M (2014-2019)
  • TABLE 41 EUROPE SLEEPING AIDS MARKET, BY OFFERING, $M (2020-2030)
  • TABLE 42 EUROPE SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014-2019)
  • TABLE 43 EUROPE SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2020-2030)
  • TABLE 44 EUROPE SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014-2019)
  • TABLE 45 EUROPE SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2020-2030)
  • TABLE 46 EUROPE SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014-2019)
  • TABLE 47 EUROPE SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2020-2030)
  • TABLE 48 EUROPE SLEEPING AIDS MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 49 EUROPE SLEEPING AIDS MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 50 GERMANY SLEEPING AIDS MARKET, BY OFFERING, $M (2014-2019)
  • TABLE 51 GERMANY SLEEPING AIDS MARKET, BY OFFERING, $M (2020-2030)
  • TABLE 52 GERMANY SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014-2019)
  • TABLE 53 GERMANY SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2020-2030)
  • TABLE 54 GERMANY SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014-2019)
  • TABLE 55 GERMANY SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2020-2030)
  • TABLE 56 GERMANY SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014-2019)
  • TABLE 57 GERMANY SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2020-2030)
  • TABLE 58 U.K. SLEEPING AIDS MARKET, BY OFFERING, $M (2014-2019)
  • TABLE 59 U.K. SLEEPING AIDS MARKET, BY OFFERING, $M (2020-2030)
  • TABLE 60 U.K. SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014-2019)
  • TABLE 61 U.K. SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2020-2030)
  • TABLE 62 U.K. SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014-2019)
  • TABLE 63 U.K. SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2020-2030)
  • TABLE 64 U.K. SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014-2019)
  • TABLE 65 U.K. SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2020-2030)
  • TABLE 66 FRANCE SLEEPING AIDS MARKET, BY OFFERING, $M (2014-2019)
  • TABLE 67 FRANCE SLEEPING AIDS MARKET, BY OFFERING, $M (2020-2030)
  • TABLE 68 FRANCE SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014-2019)
  • TABLE 69 FRANCE SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2020-2030)
  • TABLE 70 FRANCE SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014-2019)
  • TABLE 71 FRANCE SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2020-2030)
  • TABLE 72 FRANCE SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014-2019)
  • TABLE 73 FRANCE SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2020-2030)
  • TABLE 74 ITALY SLEEPING AIDS MARKET, BY OFFERING, $M (2014-2019)
  • TABLE 75 ITALY SLEEPING AIDS MARKET, BY OFFERING, $M (2020-2030)
  • TABLE 76 ITALY SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014-2019)
  • TABLE 77 ITALY SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2020-2030)
  • TABLE 78 ITALY SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014-2019)
  • TABLE 79 ITALY SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2020-2030)
  • TABLE 80 ITALY SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014-2019)
  • TABLE 81 ITALY SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2020-2030)
  • TABLE 82 SPAIN SLEEPING AIDS MARKET, BY OFFERING, $M (2014-2019)
  • TABLE 83 SPAIN SLEEPING AIDS MARKET, BY OFFERING, $M (2020-2030)
  • TABLE 84 SPAIN SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014-2019)
  • TABLE 85 SPAIN SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2020-2030)
  • TABLE 86 SPAIN SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014-2019)
  • TABLE 87 SPAIN SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2020-2030)
  • TABLE 88 SPAIN SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014-2019)
  • TABLE 89 SPAIN SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2020-2030)
  • TABLE 90 APAC SLEEPING AIDS MARKET, BY OFFERING, $M (2014-2019)
  • TABLE 91 APAC SLEEPING AIDS MARKET, BY OFFERING, $M (2020-2030)
  • TABLE 92 APAC SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014-2019)
  • TABLE 93 APAC SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2020-2030)
  • TABLE 94 APAC SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014-2019)
  • TABLE 95 APAC SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2020-2030)
  • TABLE 96 APAC SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014-2019)
  • TABLE 97 APAC SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2020-2030)
  • TABLE 98 APAC SLEEPING AIDS MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 99 APAC SLEEPING AIDS MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 100 JAPAN SLEEPING AIDS MARKET, BY OFFERING, $M (2014-2019)
  • TABLE 101 JAPAN SLEEPING AIDS MARKET, BY OFFERING, $M (2020-2030)
  • TABLE 102 JAPAN SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014-2019)
  • TABLE 103 JAPAN SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2020-2030)
  • TABLE 104 JAPAN SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014-2019)
  • TABLE 105 JAPAN SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2020-2030)
  • TABLE 106 JAPAN SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014-2019)
  • TABLE 107 JAPAN SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2020-2030)
  • TABLE 108 CHINA SLEEPING AIDS MARKET, BY OFFERING, $M (2014-2019)
  • TABLE 109 CHINA SLEEPING AIDS MARKET, BY OFFERING, $M (2020-2030)
  • TABLE 110 CHINA SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014-2019)
  • TABLE 111 CHINA SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2020-2030)
  • TABLE 112 CHINA SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014-2019)
  • TABLE 113 CHINA SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2020-2030)
  • TABLE 114 CHINA SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014-2019)
  • TABLE 115 CHINA SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2020-2030)
  • TABLE 116 INDIA SLEEPING AIDS MARKET, BY OFFERING, $M (2014-2019)
  • TABLE 117 INDIA SLEEPING AIDS MARKET, BY OFFERING, $M (2020-2030)
  • TABLE 118 INDIA SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014-2019)
  • TABLE 119 INDIA SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2020-2030)
  • TABLE 120 INDIA SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014-2019)
  • TABLE 121 INDIA SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2020-2030)
  • TABLE 122 INDIA SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014-2019)
  • TABLE 123 INDIA SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2020-2030)
  • TABLE 124 LATAM SLEEPING AIDS MARKET, BY OFFERING, $M (2014-2019)
  • TABLE 125 LATAM SLEEPING AIDS MARKET, BY OFFERING, $M (2020-2030)
  • TABLE 126 LATAM SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014-2019)
  • TABLE 127 LATAM SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2020-2030)
  • TABLE 128 LATAM SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014-2019)
  • TABLE 129 LATAM SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2020-2030)
  • TABLE 130 LATAM SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014-2019)
  • TABLE 131 LATAM SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2020-2030)
  • TABLE 132 LATAM SLEEPING AIDS MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 133 LATAM SLEEPING AIDS MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 134 MEA SLEEPING AIDS MARKET, BY OFFERING, $M (2014-2019)
  • TABLE 135 MEA SLEEPING AIDS MARKET, BY OFFERING, $M (2020-2030)
  • TABLE 136 MEA SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014-2019)
  • TABLE 137 MEA SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2020-2030)
  • TABLE 138 MEA SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014-2019)
  • TABLE 139 MEA SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2020-2030)
  • TABLE 140 MEA SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014-2019)
  • TABLE 141 MEA SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2020-2030)
  • TABLE 142 MEA SLEEPING AIDS MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 143 MEA SLEEPING AIDS MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 144 SANOFI - AT A GLANCE
  • TABLE 145 SANOFI - KEY FINANCIAL SUMMARY
  • TABLE 146 MERCK & CO. INC. - AT A GLANCE
  • TABLE 147 MERCK & CO. INC. - KEY FINANCIAL SUMMARY
  • TABLE 148 KONINKLIJKE PHILIPS N.V. - AT A GLANCE
  • TABLE 149 KONINKLIJKE PHILIPS N.V. - KEY FINANCIAL SUMMARY
  • TABLE 150 PFIZER INC. - AT A GLANCE
  • TABLE 151 PFIZER INC. - KEY FINANCIAL SUMMARY
  • TABLE 152 SLEEPMED INC. - AT A GLANCE
  • TABLE 153 CADWELL INDUSTRIES INC. - AT A GLANCE
  • TABLE 154 NATUS MEDICAL INCORPORATED - AT A GLANCE
  • TABLE 155 NATUS MEDICAL INCORPORATED - KEY FINANCIAL SUMMARY
  • TABLE 156 DRIVE DEVILBISS HEALTHCARE - AT A GLANCE
  • TABLE 157 TAKEDA PHARMACEUTICAL COMPANY LIMITED - AT A GLANCE
  • TABLE 158 TAKEDA PHARMACEUTICAL COMPANY LIMITED - KEY FINANCIAL SUMMARY
  • TABLE 159 COMPUMEDICS LIMITED - AT A GLANCE
  • TABLE 160 COMPUMEDICS LIMITED - KEY FINANCIAL SUMMARY
  • TABLE 161 TEMPUR SEALY INTERNATIONAL INC. - AT A GLANCE
  • TABLE 162 TEMPUR SEALY INTERNATIONAL INC. - KEY FINANCIAL SUMMARY
  • TABLE 163 GLAXOSMITHKLINE PLC - AT A GLANCE
  • TABLE 164 GLAXOSMITHKLINE PLC - KEY FINANCIAL SUMMARY
  • TABLE 165 SERTA SIMMONS BEDDING LLC - AT A GLANCE
  • TABLE 166 RESMED INC. - AT A GLANCE
  • TABLE 167 RESMED INC. - KEY FINANCIAL SUMMARY
  • TABLE 168 FISHER & PAYKEL HEALTHCARE LIMITED - AT A GLANCE
  • TABLE 169 FISHER & PAYKEL HEALTHCARE LIMITED - KEY FINANCIAL SUMMARY
  • TABLE 170 LOWENSTEIN MEDICAL GMBH & CO. KG - AT A GLANCE
  • TABLE 171 BMC MEDICAL CO. LTD. - AT A GLANCE
  • TABLE 172 SOMNOMED LIMITED - AT A GLANCE
  • TABLE 173 SOMNOMED LIMITED - KEY FINANCIAL SUMMARY
  • TABLE 174 BRAEBON MEDICAL CORPORATION - AT A GLANCE

LIST OF FIGURES

  • FIG 1 RESEARCH SCOPE
  • FIG 2 RESEARCH METHODOLOGY
  • FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH
  • FIG 4 SPLIT OF PRIMARY RESEARCH BY TYPE
  • FIG 5 SPLIT OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
  • FIG 6 SPLIT OF PRIMARY RESEARCH BY COMPANY TYPE
  • FIG 7 SPLIT OF PRIMARY RESEARCH BY COMPANY REVENUE AND CORPORATE DESIGNATION
  • FIG 8 DATA TRIANGULATION APPROACH
  • FIG 9 GLOBAL SLEEPING AIDS MARKET SUMMARY
  • FIG 10 PROJECTED GLOBAL AGING POPULATION ABOVE 60 YEARS OF AGE
  • FIG 11 BARGAINING POWER OF BUYERS
  • FIG 12 BARGAINING POWER OF SUPPLIERS
  • FIG 13 INTENSITY OF RIVALRY
  • FIG 14 THREAT OF NEW ENTRANTS
  • FIG 15 THREAT OF SUBSTITUTES
  • FIG 16 GLOBAL SLEEPING AIDS MARKET SNAPSHOT (2019)
  • FIG 17 GLOBAL SLEEPING AIDS MARKET, BY OFFERING, $M (2014-2030)
  • FIG 18 GLOBAL SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014-2030)
  • FIG 19 GLOBAL SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014-2030)
  • FIG 20 GLOBAL SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014-2030)
  • FIG 21 MAJOR MARKETS FOR SLEEPING AIDS
  • FIG 22 GLOBAL SLEEPING AIDS MARKET, BY REGION, $M (2014-2030)
  • FIG 23 NORTH AMERICA SLEEPING AIDS MARKET SNAPSHOT
  • FIG 24 NORTH AMERICA SLEEPING AIDS MARKET, BY OFFERING, $M (2014-2030)
  • FIG 25 NORTH AMERICA SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014-2030)
  • FIG 26 NORTH AMERICA SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014-2030)
  • FIG 27 NORTH AMERICA SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014-2030)
  • FIG 28 NORTH AMERICA SLEEPING AIDS MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 29 EUROPE SLEEPING AIDS MARKET SNAPSHOT
  • FIG 30 EUROPE SLEEPING AIDS MARKET, BY OFFERING, $M (2014-2030)
  • FIG 31 EUROPE SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014-2030)
  • FIG 32 EUROPE SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014-2030)
  • FIG 33 EUROPE SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014-2030)
  • FIG 34 EUROPE SLEEPING AIDS MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 35 APAC SLEEPING AIDS MARKET SNAPSHOT
  • FIG 36 APAC SLEEPING AIDS MARKET, BY OFFERING, $M (2014-2030)
  • FIG 37 APAC SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014-2030)
  • FIG 38 APAC SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014-2030)
  • FIG 39 APAC SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014-2030)
  • FIG 40 APAC SLEEPING AIDS MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 41 LATAM SLEEPING AIDS MARKET SNAPSHOT
  • FIG 42 LATAM SLEEPING AIDS MARKET, BY OFFERING, $M (2014-2030)
  • FIG 43 LATAM SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014-2030)
  • FIG 44 LATAM SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014-2030)
  • FIG 45 LATAM SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014-2030)
  • FIG 46 LATAM SLEEPING AIDS MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 47 MEA SLEEPING AIDS MARKET SNAPSHOT
  • FIG 48 MEA SLEEPING AIDS MARKET, BY OFFERING, $M (2014-2030)
  • FIG 49 MEA SLEEPING AID MEDICATION MARKET, BY TYPE, $M (2014-2030)
  • FIG 50 MEA SLEEP APNEA DEVICES MARKET, BY TYPE, $M (2014-2030)
  • FIG 51 MEA SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2014-2030)
  • FIG 52 MEA SLEEPING AIDS MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 53 PRODUCT BENCHMARKING OF KEY PLAYERS
  • FIG 54 SANOFI - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 55 MERCK & CO. INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 56 KONINKLIJKE PHILIPS N.V. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 57 PFIZER INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 58 NATUS MEDICAL INCORPORATED - REVENUE SPLIT BY PRODUCT MARKET, PRODUCT CATEGORY, AND GEOGRAPHY (2019)
  • FIG 59 TAKEDA PHARMACEUTICAL COMPANY LIMITED - REVENUE SPLIT BY GEOGRAPHY (2020)
  • FIG 60 COMPUMEDICS LIMITED - REVENUE SPLIT BY GEOGRAPHY (2019)
  • FIG 61 TEMPUR SEALY INTERNATIONAL INC. - REVENUE SPLIT BY GEOGRAPHY (2019)
  • FIG 62 GLAXOSMITHKLINE PLC - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 63 RESMED INC. - REVENUE SPLIT BY PRODUCT AND GEOGRAPHY (2019)
  • FIG 64 FISHER & PAYKEL HEALTHCARE LIMITED - REVENUE SPLIT BY PRODUCT GROUP AND GEOGRAPHY (2019)
  • FIG 65 SOMNOMED LIMITED - REVENUE SPLIT BY GEOGRAPHY (2019)